Vitamin K
Adult
Cell Proliferation
/ drug effects
Cells, Cultured
Child
Child, Preschool
Cyclosporine
/ pharmacology
Dermatitis, Atopic
/ drug therapy
Female
Healthy Volunteers
Humans
Immunosuppressive Agents
/ administration & dosage
Leukocytes, Mononuclear
/ drug effects
Male
Methylprednisolone
/ pharmacology
Tacrolimus
/ pharmacology
Vitamin K 2
/ administration & dosage
immunosuppressive efficacy
pediatric atopic dermatitis
peripheral blood mononuclear cells
vitamin K2
Journal
Pediatrics international : official journal of the Japan Pediatric Society
ISSN: 1442-200X
Titre abrégé: Pediatr Int
Pays: Australia
ID NLM: 100886002
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
13
05
2019
revised:
25
07
2019
accepted:
24
09
2019
pubmed:
29
9
2019
medline:
4
9
2020
entrez:
28
9
2019
Statut:
ppublish
Résumé
Over 20 kinds of steroids, tacrolimus ointments, and cyclosporine capsules are usually recommended for the treatment of atopic dermatitis (AD), depending on the symptoms of patients. However, several side effects sometimes occur with the extensive use of these agents for the treatment of pediatric AD patients. The purpose of this study was to explore whether vitamin K The immunosuppressive efficacy of vitamin K The mean (SD) IC Vitamin K
Sections du résumé
BACKGROUND
BACKGROUND
Over 20 kinds of steroids, tacrolimus ointments, and cyclosporine capsules are usually recommended for the treatment of atopic dermatitis (AD), depending on the symptoms of patients. However, several side effects sometimes occur with the extensive use of these agents for the treatment of pediatric AD patients. The purpose of this study was to explore whether vitamin K
METHODS
METHODS
The immunosuppressive efficacy of vitamin K
RESULTS
RESULTS
The mean (SD) IC
CONCLUSION
CONCLUSIONS
Vitamin K
Substances chimiques
Immunosuppressive Agents
0
Vitamin K 2
11032-49-8
Cyclosporine
83HN0GTJ6D
Tacrolimus
WM0HAQ4WNM
Methylprednisolone
X4W7ZR7023
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1188-1195Subventions
Organisme : State Scholarship Fund of China Scholarship Council
ID : 201808420024
Organisme : Japan China Sasakawa Medical Fellowship
ID : 2017816
Informations de copyright
© 2019 Japan Pediatric Society.
Références
Dainichi T, Kitoh A, Otsuka A et al. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat. Immunol. 2018; 19: 1286-98.
Cipriani F, Ricci G, Leoni MC et al. Autoimmunity in atopic dermatitis: Biomarker or simply epiphenomenon? J. Dermatol. 2014; 41: 569-76.
Peters AS, Kellberger J, Vogelberg C et al. Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: A prospective cohort study. J. Allergy Clin. Immunol. 2010; 126: e3.
Saeki H, Iizuka H, Mori Y et al. Prevalence of atopic dermatitis in Japanese elementary schoolchildren. Br. J. Dermatol. 2005; 152: 110-14.
Katayama I, Aihara M, Ohya Y et al. Japanese guidelines for atopic dermatitis 2017. Allergol. Int. 2017; 66: 230-47.
Schmitt J, Schakel K, Schmitt N, Meurer M. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm. Venereol. 2007; 87: 100-11.
Hernández-Martín A, Noguera-Morel L, Bernardino-Cuesta B et al. Cyclosporine A for severe atopic dermatitis in children. efficacy and safety in a retrospective study of 63 patients. J. Eur. Acad. Dermatol. Venereol. 2017; 31: 837-42.
González-López G, Ceballos-Rodríguez RM, González-López JJ, Feito Rodríguez M, Herranz-Pinto P. Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis. Br. J. Dermatol 2017; 177: 688-95.
Meng K, Xu W, Miura T et al. The effects of vitamin K1 and vitamin K2 on the proliferation, cytokine production and regulatory T-cell frequency in peripheral blood mononuclear cells of paediatric atopic dermatitis patients. Exp. Dermatol. 2018; 27: 1058-60.
Koitaya N, Sekiguchi M, Tousen Y et al. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women. J. Bone Miner. Metab. 2014; 32: 142-50.
Xu W, Meng K, Tu Y et al. Tetrandrine potentiates the glucocorticoid pharmacodynamics via inhibiting P-glycoprotein and mitogen-activated protein kinase in mitogen-activated human peripheral blood mononuclear cells. Eur. J. Pharmacol. 2017; 807: 102-08.
Xu W, Meng K, Kusano J et al. Immunosuppressive efficacy of tetrandrine combined with methylprednisolone against mitogen-activated peripheral blood mononuclear cells of haemodialysis patients. Clin. Exp. Pharmacol. Physiol. 2017; 44: 924-31.
Xu W, Wang X, Tu Y et al. Plant-derived alkaloid sinomenine potentiates glucocorticoid pharmacodynamics in mitogen-activated human peripheral blood mononuclear cells by regulating the translocation of glucocorticoid receptor. Phytother. Res. 2019; 33: 187-96.
Sugiyama K, Isogai K, Toyama A et al. Pharmacodynamic parameters of immunosuppressive drugs are not correlated with age, duration of dialysis, percentage of lymphocytes or lymphocyte stimulation index in renal transplant recipients. Biol. Pharm. Bull. 2008; 31: 2146-49.
Chen S, Sugiyama K, Inamura M et al. Effects of insulin on pharmacodynamics of immunosuppressive drugs against mitogen-activated human peripheral blood mononuclear cells. Immunopharmacol. Immunotoxicol. 2016; 38: 372-78.
Hatanaka H, Ishizawa H, Nakamura Y et al. Effects of vitamin K3 and K5 on proliferation, cytokine production, and regulatory T cell-frequency in human peripheral-blood mononuclear cells. Life Sci. 2014; 99: 61-8.
Weber LT, Dötsch J. Therapeutic monitoring of immunosuppressive drugs in pediatric patients: special considerations. Expert Rev. Clin. Pharmacol. 2016; 9: 1001-03.
Akdis CA, Akdis M, Simon D et al. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J. Invest. Dermatol. 1999; 113: 628-34.
Myneni VD, Mezey E. Immunomodulatory effect of vitamin K2: Implications for bone health. Oral Dis. 2018; 24: 67-71.
Ohsaki Y, Shirakawa H, Miura A et al. Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor kappaB through the repression of IKKalpha/beta phosphorylation. J. Nutr. Biochem. 2010; 21: 1120-6.
Gerondakis S, Fulford TS, Messina NL, Grumont RJ. NF-kappaB control of T cell development. Nat. Immunol. 2014; 15: 15-25.
Hirano T, Oka K, Takeuchi H et al. Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation: Marked difference between prednisolone and methylprednisolone. Transplantation 1994; 57: 1341-48.
Hirano T, Oka K, Takeuchi H et al. Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: Possible implications for individual therapeutic efficacy. Clin. Pharmacol. Ther. 1997; 62: 652-64.
Hirano T, Oka K, Umezawa Y, Hirata M, Oh-i T, Koga M. Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis. Clin. Pharmacol. Ther. 1998; 63: 465-70.
Hirano T, Kawamura T, Fukuda S et al. Implication of cholesterol in cyclosporine pharmacodynamics in minimal change nephrotic syndrome. Clin. Pharmacol. Ther. 2003; 74: 581-90.